Literature DB >> 23543511

Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Jessie Morgan1, Lauren Young, William McGuire.   

Abstract

BACKGROUND: Early enteral feeding practices are potentially modifiable risk factors for necrotising enterocolitis in very preterm or very low birth weight (VLBW) infants. Observational studies suggest that conservative feeding regimens that include slowly advancing enteral feed volumes reduce the risk of necrotising enterocolitis. However, slow feed advancement may delay establishment of full enteral feeding and be associated with metabolic and infectious morbidities secondary to prolonged exposure to parenteral nutrition.
OBJECTIVES: To determine the effect of slow rates of enteral feed advancement on the incidence of necrotising enterocolitis, mortality and other morbidities in very preterm or VLBW infants. SEARCH
METHODS: We used the standard search strategy of the Cochrane Neonatal Review Group. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 12), MEDLINE, EMBASE and CINAHL (to December 2012), conference proceedings, and previous reviews. SELECTION CRITERIA: Randomised or quasi-randomised controlled trials that assessed the effect of slow (up to 24 ml/kg/day) versus faster rates of advancement of enteral feed volumes upon the incidence of necrotising enterocolitis in very preterm or VLBW infants. DATA COLLECTION AND ANALYSIS: Data collection and analysis was performed using the standard methods of the Cochrane Neonatal Review Group. MAIN
RESULTS: We identified five randomised controlled trials in which a total of 588 infants participated. Few participants were extremely preterm, extremely low birth weight or growth restricted. The trials defined slow advancement as daily increments of 15 to 20 ml/kg and faster advancement as 30 to 35 ml/kg. Meta-analyses did not detect statistically significant effects on the risk of necrotising enterocolitis (typical risk ratio (RR) 0.97, 95% confidence interval (CI) 0.54 to 1.74) or all-cause mortality (RR 1.41, 95% CI 0.81 to 2.74). Infants who had slow advancement took significantly longer to regain birth weight (reported median differences two to six days) and to establish full enteral feeding (two to five days). AUTHORS'
CONCLUSIONS: The available trial data suggest that advancing enteral feed volumes at slow rather than faster rates does not reduce the risk of necrotising enterocolitis in very preterm or VLBW infants. Advancing the volume of enteral feeds at slow rates results in several days delay in regaining birth weight and establishing full enteral feeds but the long term clinical importance of these effects is unclear. The applicability of these findings to extremely preterm, extremely low birth weight or growth restricted infants is limited. Further randomised controlled trials in these populations may be warranted to resolve this uncertainty.

Entities:  

Mesh:

Year:  2013        PMID: 23543511     DOI: 10.1002/14651858.CD001241.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  13 in total

Review 1.  Intestinal microbiota and its relationship with necrotizing enterocolitis.

Authors:  Ravi Mangal Patel; Patricia W Denning
Journal:  Pediatr Res       Date:  2015-05-20       Impact factor: 3.756

Review 2.  Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Authors:  Sam J Oddie; Lauren Young; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2021-08-24

Review 3.  Pathophysiology and current management of necrotizing enterocolitis.

Authors:  Himabindu Kasivajjula; Akhil Maheshwari
Journal:  Indian J Pediatr       Date:  2014-03-22       Impact factor: 1.967

Review 4.  Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Authors:  Sam J Oddie; Lauren Young; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2017-08-30

Review 5.  Evidence-based feeding strategies before and after the development of necrotizing enterocolitis.

Authors:  Misty Good; Chhinder P Sodhi; David J Hackam
Journal:  Expert Rev Clin Immunol       Date:  2014-06-05       Impact factor: 4.473

6.  Impact of a new aggressive nutrition policy incorporating early introduction of parenteral nutrition and mother's own milk on growth of preterm infants.

Authors:  Chuen Siang Low; Jacqueline J Ho; Revathy Nallusamy
Journal:  World J Pediatr       Date:  2016-06-10       Impact factor: 2.764

7.  Necrotizing enterocolitis and focal intestinal perforation in neonatal intensive care units in the state of baden-württemberg, Germany.

Authors:  Thomas Böhler; Ingo Bruder; Peter Ruef; Jörg Arand; Manfred Teufel; Matthias Mohrmann; Roland Hentschel
Journal:  Pediatr Rep       Date:  2014-02-17

8.  Delayed initiation but not gradual advancement of enteral formula feeding reduces the incidence of necrotizing enterocolitis (NEC) in preterm pigs.

Authors:  Nada Ghoneim; Caroline Bauchart-Thevret; Berthe Oosterloo; Barbara Stoll; Madhulika Kulkarni; Miguel Saenz de Pipaon; Irving J Zamora; Oluyinka O Olutoye; Brian Berg; Anja Wittke; Douglas G Burrin
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

9.  Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates.

Authors:  M S El-Shimi; H A Awad; M A Abdelwahed; M H Mohamed; S M Khafagy; G Saleh
Journal:  Int J Pediatr       Date:  2015-03-12

10.  Comparing the intestinal transcriptome of Meishan and Large White piglets during late fetal development reveals genes involved in glucose and lipid metabolism and immunity as valuable clues of intestinal maturity.

Authors:  Ying Yao; Valentin Voillet; Maeva Jegou; Magali SanCristobal; Samir Dou; Véronique Romé; Yannick Lippi; Yvon Billon; Marie-Christine Père; Gaëlle Boudry; Laure Gress; Nathalie Iannucelli; Pierre Mormède; Hélène Quesnel; Laurianne Canario; Laurence Liaubet; Isabelle Le Huërou-Luron
Journal:  BMC Genomics       Date:  2017-08-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.